UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 5, 2015 4:00 P.M.

Form:	F-1
CIK: 0001621227 Company Name: Adaptimmune Therapeutics PLC File Number: 333-203267